Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-25-043042
Filing Date
2025-11-24
Accepted
2025-11-24 09:21:01
Documents
2
Period of Report
2025-11-24

Document Format Files

Seq Description Document Type Size
1 6-K ef20059892_6k.htm 6-K 9727
2 EXHIBIT 99.1 ef20059892_ex99-1.htm EX-99.1 13263
  Complete submission text file 0001140361-25-043042.txt   24057
Mailing Address JOSHUA DAWSON HOUSE DAWSON STREET DUBLIN 2 L2 D02 RY95
Business Address JOSHUA DAWSON HOUSE DAWSON STREET DUBLIN 2 L2 D02 RY95 353 1 437 8334
GH Research PLC (Filer) CIK: 0001855129 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40530 | Film No.: 251509911
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)